An Overlooked Long-Term Side Effect
A Q&A with medical oncologist Patricia Ganz on chemotherapy-related nerve damage.
Progress Against Cancer
A Q&A with medical oncologist Patricia Ganz on chemotherapy-related nerve damage.
More Americans are beating childhood cancer, but many experience effects later in life such as high blood pressure.
Study: Urban native populations may have decreased survival following invasive prostate and breast cancer. Urban American Indians and Alaskan Natives (AIAN) appear to have lower survival rates following invasive prostate and breast cancer as...
Study: Non-obese diabetic African-American women may have a higher risk of developing ER-negative breast cancer.
The type of fat and its location in the body appear to play a role in the risk of developing cancer, a study in the AACR journal Cancer Prevention Research.
The FDA expanded the use of a targeted therapy to include certain patients with two types of non-Hodgkin lymphoma.
The FDA approved a molecularly targeted therapeutic for adults with mantle cell lymphoma that has progressed despite at least one prior treatment.
The FDA approved the second of a revolutionary new type of immunotherapy known as chimeric antigen receptor (CAR) T-cell therapy.
Mexican-Americans face different – and perhaps greater – risks for developing liver cancer than Mexican residents. Liver cancer is a relatively rare cancer type, but its incidence and mortality have been on the rise...
A study suggests working within a religious framework may help eas cultural barriers to cancer screening with mammograms.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More